Skip to content
10-Q

Quarterly Report

PetLife Pharmaceuticals, Inc.

0001493152-18-000833

← back to feed
Filed
Jan 22, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2018 · Jan 15, 2018 73.95M sh
Operating Cash Flow Q1 2018 · Nov 30, 2017 −$119.94K
Operating Cash Flow Q1 2018 · Nov 30, 2016 −$182.53K
Cash And Equivalents Q1 2018 · Nov 30, 2017 $54.31K
Cash And Equivalents Q1 2018 · Aug 31, 2017 $54.25K
Cash And Equivalents Q1 2018 · Nov 30, 2016 $29K
Cash And Equivalents Q1 2018 · Aug 31, 2016 $1.17K
Stockholders Equity Q1 2018 · Nov 30, 2017 −$1.77M
Stockholders Equity Q1 2018 · Aug 31, 2017 −$1.38M
Current Liabilities Q1 2018 · Nov 30, 2017 $1.83M
Current Liabilities Q1 2018 · Aug 31, 2017 $1.44M
Total Liabilities Q1 2018 · Nov 30, 2017 $1.83M
Total Liabilities Q1 2018 · Aug 31, 2017 $1.44M
Current Assets Q1 2018 · Nov 30, 2017 $57.64K
Current Assets Q1 2018 · Aug 31, 2017 $55K
Total Assets Q1 2018 · Nov 30, 2017 $57.64K
Total Assets Q1 2018 · Aug 31, 2017 $55K
Net Income Q1 2018 · Nov 30, 2017 −$466.66K
Net Income Q1 2018 · Nov 30, 2016 −$19.12M
Operating Income Q1 2018 · Nov 30, 2017 −$193.31K
Operating Income Q1 2018 · Nov 30, 2016 −$19.11M